NDC 47781-473
buprenorphine buccal film
Buprenorphine Buccal
buprenorphine buccal film is a Buccal Film in the Human Prescription Drug category. It is labeled and distributed by Alvogen, Inc.. The primary component is Buprenorphine Hydrochloride.
| Product ID | 47781-473_62b1a9fe-2e29-1535-e7d6-327240efa309 |
| NDC | 47781-473 |
| Product Type | Human Prescription Drug |
| Proprietary Name | buprenorphine buccal film |
| Generic Name | Buprenorphine Buccal |
| Dosage Form | Film |
| Route of Administration | BUCCAL |
| Marketing Start Date | 2021-08-04 |
| Marketing Category | ANDA / |
| Application Number | ANDA211594 |
| Labeler Name | Alvogen, Inc. |
| Substance Name | BUPRENORPHINE HYDROCHLORIDE |
| Active Ingredient Strength | 600 ug/1 |
| Pharm Classes | Partial Opioid Agonists [MoA],Partial Opioid Agonist [EPC] |
| DEA Schedule | CIII |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |